The cancer‐suppressive effect of IL‐1β was confirmed in a mouse model for myeloma showing that IL‐1β (as well as IL‐1α) neutralization by anakinra severely impaired myeloma clearance by tumor‐specific Th1 cells and tumor‐infiltrating macrophages.162. Here, IL1A is linked to plasma cell myeloma.